<DOC>
	<DOCNO>NCT03002051</DOCNO>
	<brief_summary>To evaluate clinical efficacy safety novel lumen-apposing FCSEMS EUS-guided transenteric drainage PFC biliary tree include GB</brief_summary>
	<brief_title>EUS-guided Transenteric Drainage With Novel Lumen-apposing Metal Stent</brief_title>
	<detailed_description>Patients follow condition would recruit drainage EUS guidance new lumen appose FCSEMS - Symptomatic infected pancreatic pseudocyst walled-off necrosis ( WON ) ( SPAXUS 16 10 mm ) - Acute cholecystitis inoperable malignant disease ( SPAXUS 10 mm ) - Acute cholecystitis benign condition high-risk operation ( SPAXUS 10 mm ) - Long-term cholecystostomy high-risk operation ( SPAXUS 10 mm ) - Symptomatic malignant obstruction distal CBD unsuccessful transpapillary approach ( diameter CBD &gt; 10 mm ) ( SPAXUS 8 10 mm ) Outcome paramaters include technical clinical success , adverse event .</detailed_description>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Cholecystitis , Acute</mesh_term>
	<mesh_term>Pancreatic Pseudocyst</mesh_term>
	<criteria>Patient must meet follow inclusion criterion eligible enrollment study . Pancreatobiliary diseases eligible EUSguided transenteric drainage The patient age 20 80 year . Legally acceptable representative must capable give write informed consent prior participation study Target lesion accessible transenteric approach The woman childbearing age must negative pregnancy test order participate study The patient willing able comply schedule visit , treatment plan , laboratory test , study procedure The patient unacceptable condition ( e.g. , physiological , familyism , social , geographical ) medical followup adaptation study . Patient present follow include study . Inaccessible EUSguided approach Bleeding tendency : International normalized ratio ( INR ) prothrombin time &lt; 1.5 platelet conunt &lt; 60,000/mm3 Patients Disseminated Intravascular Coagulation syndrome ( DIC ) Patients take medicine cause hemorrhage ( e.g. , Aspirin , Wafarin etc . ) Patients serious disease medical condition Patients past medical history significant neurologic Psychiatric disorder dementia seizure Unstable heart disease despite treatment , recent myocardial infarction within 6 month ( Even though MI diagnose within 6 month , become stable presently , patient possible participate ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>